Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin

Lignende værker

• Pharmacokinetics and pharmacodynamics of warfarin at steady state.
  af: Routledge, P A, et al.
  Udgivet: (1979)
• Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects
  af: Dingemanse, Jasper, et al.
  Udgivet: (2002)
• Absence of Pharmacokinetic and Pharmacodynamic Interactions between Almorexant and Warfarin in Healthy Subjects
  af: Dingemanse, Jasper, et al.
  Udgivet: (2013)
• Comparison of the pharmacokinetics, pharmacodynamics and tolerability of tezosentan between caucasian and Japanese subjects
  af: Dingemanse, Jasper, et al.
  Udgivet: (2006)
• The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease
  af: Piccini, P., et al.
  Udgivet: (2000)